A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color

Sadick Research Group, New York

Virginia Clinical Research, Inc., Norfolk

Wilmington Health Family Medicine, Wilmington

Dermatology & Laser Center of Charleston, Charleston

Advanced Medical Research, Sandy Springs

Skin Care Physicians of Georgia, Macon

Solutions Through Advanced Research, Jacksonville

PureSkin Dermatology, Orlando

Savin Medical Group, LLC, Miami Lakes

Skin Care Research, Inc, Hollywood

Miami Dermatology and Laser Research, Miami

Encore Medical Research of Boynton Beach, Boynton Beach

Total Skin and Beauty Dermatology Center, PC, Birmingham

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Revival Research Institute - Troy, Troy

Oakland Hills Dermatology, Auburn Hills

Washington University School of Medicine, St Louis

Skin Specialists, P.C, Omaha

Arlington Research Center, Inc, Arlington

Clinical Trial Network, Houston

Complete Dermatology, Sugar Land

Progressive Clinical Research, San Antonio

Texas Dermatology and Laser Specialists, San Antonio

Dermatology Clinical Research Center of San Antonio, San Antonio

Dermatology Research Associates, Los Angeles

Wallace Medical Group, Inc., Los Angeles

Axon Clinical Research, Inglewood

Clinical Science Institute, Santa Monica

Cura Clinical Research, Sherman Oaks

Avance Clinical Trials Inc, Laguna Niguel

First OC Dermatology, Fountain Valley

Cura Clinical Research, Palmdale

Center For Dermatology Clinical Research, Inc., Fremont

University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento

UConn Health, Farmington

Allcutis Research, Inc., Beverly